Brett Maas welcomes you to his mixture of Business, Investing, and the latest news from his perspective.
Jan
05

Echo Therapeutics Corporate Profile

By
Echo Therapeutics

Echo Therapeutics

Echo Therapeutics is a transdermal medical device company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude™ SkinPrep System as a platform technology for transdermal drug delivery. Echo believes that the Symphony tCGM System will change the paradigm of invasive, needle-based, episodic glucose testing in the diabetes consumer and hospital critical care markets to one of continuous, needle-free monitoring. Echo is also developing its needle-free Prelude SkinPrep System as a platform technology for enhanced skin permeation to allow for transdermal drug delivery of a wide range of FDA-approved products.

Want to learn more? Open, Print, and Read the full corporate profile and power point presentation below.

Echo Therapeutics Corporate Profile Link

Echo Therapeutics Power Point Link

Leave a Reply